title: Clinical guidelines for overactive bladder.
authors.affiliation: Department of Urology, Fukushima Medical University, Fukushima-shi, Fukushima, Japan. yamaosa@fmu.ac.jp
authors.forename: Osamu
authors.initials: O
authors.lastname: Yamaguchi
authors.forename: Osamu
authors.initials: O
authors.lastname: Nishizawa
authors.forename: Masayuki
authors.initials: M
authors.lastname: Takeda
authors.forename: Osamu
authors.initials: O
authors.lastname: Yokoyama
authors.forename: Yukio
authors.initials: Y
authors.lastname: Homma
authors.forename: Hidehiro
authors.initials: H
authors.lastname: Kakizaki
authors.forename: Kenji
authors.initials: K
authors.lastname: Obara
authors.forename: Momokazu
authors.initials: M
authors.lastname: Gotoh
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Igawa
authors.forename: Naarihito
authors.initials: N
authors.lastname: Seki
authors.forename: Masaki
authors.initials: M
authors.lastname: Yoshida
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D032763:Behavior Control; D001905:Botulinum Toxins / Q000627:therapeutic use; D002211:Capsaicin / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004224:Diterpenes / Q000627:therapeutic use; D005422:Flavoxate / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D018689:Sensory System Agents / Q000627:therapeutic use; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D018726:Anti-Dyskinesia Agents; D000928:Antidepressive Agents; D018680:Cholinergic Antagonists; D004224:Diterpenes; D010276:Parasympatholytics; D018689:Sensory System Agents; D005422:Flavoxate; C024353:resiniferatoxin; D001905:Botulinum Toxins; D002211:Capsaicin